Clinical Trial Update: Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue [NA]

View source ↗

Summary

Dana-Farber Cancer Institute is sponsoring a clinical trial examining the effects of physical activity on cellular proliferation and immune markers in benign br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | NA | Status: ACTIVE_NOT_RECRUITING